In a Hot Political Climate, Drug Prices Continue to Rise
Executive Summary
US drug prices continued to rise at rates far greater than inflation in 1998, according to data released by pharmacy benefit management company Express Scripts Inc. Not only are drug prices high, but the rate of increase keeps escalating,
You may also be interested in...
Pfizer Picks on France
Drug price fixing throughout Europe has long frustrated the pharmaceutical industry, but Pfizer's CEO has singled out France as the worst perpetrator.
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.